N-[5-(5-chloro-6-methyl-1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]acetamide;N-[5-(5-ethyl-6-methyl-1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]-4-methylpiperazine-1-carboxamide;N-[5-(5-fluoro-6-methyl-1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]acetamide;N-[5-(5-fluoro-6-methyl-1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]-4-methylpiperazine-1-carboxamide;bis(N-[5-(5-fluoro-6-methyl-1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]piperidine-1-carboxamide);N-[5-[6-(trifluoromethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]acetamide

C109H117ClF7N41O7 — CID 162183242

IUPACN-[5-(5-chloro-6-methyl-1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]acetamide;N-[5-(5-ethyl-6-methyl-1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]-4-methylpiperazine-1-carboxamide;N-[5-(5-fluoro-6-methyl-1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]acetamide;N-[5-(5-fluoro-6-methyl-1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]-4-methylpiperazine-1-carboxamide;bis(N-[5-(5-fluoro-6-methyl-1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]piperidine-1-carboxamide);N-[5-[6-(trifluoromethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]acetamide
SMILESCC(=O)Nc1cn[nH]c1-c1nc2cc(Cl)c(C)cc2[nH]1.CC(=O)Nc1cn[nH]c1-c1nc2cc(F)c(C)cc2[nH]1.CC(=O)Nc1cn[nH]c1-c1nc2ccc(C(F)(F)F)cc2[nH]1.CCc1cc2nc(-c3[nH]ncc3NC(=O)N3CCN(C)CC3)[nH]c2cc1C.Cc1cc2[nH]c(-c3[nH]ncc3NC(=O)N3CCCCC3)nc2cc1F.Cc1cc2[nH]c(-c3[nH]ncc3NC(=O)N3CCCCC3)nc2cc1F.Cc1cc2[nH]c(-c3[nH]ncc3NC(=O)N3CCN(C)CC3)nc2cc1F
InChIInChI=1S/C19H25N7O.C17H20FN7O.2C17H19FN6O.C13H12ClN5O.C13H10F3N5O.C13H12FN5O/c1-4-13-10-15-14(9-12(13)2)21-18(22-15)17-16(11-20-24-17)23-19(27)26-7-5-25(3)6-8-26;1-10-7-12-13(8-11(10)18)21-16(20-12)15-14(9-19-23-15)22-17(26)25-5-3-24(2)4-6-25;2*1-10-7-12-13(8-11(10)18)21-16(20-12)15-14(9-19-23-15)22-17(25)24-5-3-2-4-6-24;1-6-3-9-10(4-8(6)14)18-13(17-9)12-11(5-15-19-12)16-7(2)20;1-6(22)18-10-5-17-21-11(10)12-19-8-3-2-7(13(14,15)16)4-9(8)20-12;1-6-3-9-10(4-8(6)14)18-13(17-9)12-11(5-15-19-12)16-7(2)20/h9-11H,4-8H2,1-3H3,(H,20,24)(H,21,22)(H,23,27);7-9H,3-6H2,1-2H3,(H,19,23)(H,20,21)(H,22,26);2*7-9H,2-6H2,1H3,(H,19,23)(H,20,21)(H,22,25);3-5H,1-2H3,(H,15,19)(H,16,20)(H,17,18);2-5H,1H3,(H,17,21)(H,18,22)(H,19,20);3-5H,1-2H3,(H,15,19)(H,16,20)(H,17,18)
InChIKeyZPHYPECYSQOADF-UHFFFAOYSA-N
MW2281.85 g/mol
LogP19.78
Rot. Bonds15

About N-[5-(5-chloro-6-methyl-1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]acetamide;N-[5-(5-ethyl-6-methyl-1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]-4-methylpiperazine-1-carboxamide;N-[5-(5-fluoro-6-methyl-1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]acetamide;N-[5-(5-fluoro-6-methyl-1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]-4-methylpiperazine-1-carboxamide;bis(N-[5-(5-fluoro-6-methyl-1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]piperidine-1-carboxamide);N-[5-[6-(trifluoromethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]acetamide

N-[5-(5-chloro-6-methyl-1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]acetamide;N-[5-(5-ethyl-6-methyl-1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]-4-methylpiperazine-1-carboxamide;N-[5-(5-fluoro-6-methyl-1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]acetamide;N-[5-(5-fluoro-6-methyl-1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]-4-methylpiperazine-1-carboxamide;bis(N-[5-(5-fluoro-6-methyl-1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]piperidine-1-carboxamide);N-[5-[6-(trifluoromethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]acetamide (PubChem CID 162183242) has the molecular formula C109H117ClF7N41O7 and a molecular weight of 2281.85 g/mol. Its IUPAC name is N-[5-(5-chloro-6-methyl-1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]acetamide;N-[5-(5-ethyl-6-methyl-1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]-4-methylpiperazine-1-carboxamide;N-[5-(5-fluoro-6-methyl-1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]acetamide;N-[5-(5-fluoro-6-methyl-1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]-4-methylpiperazine-1-carboxamide;bis(N-[5-(5-fluoro-6-methyl-1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]piperidine-1-carboxamide);N-[5-[6-(trifluoromethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]acetamide.

Molecular Properties

Compound NameN-[5-(5-chloro-6-methyl-1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]acetamide;N-[5-(5-ethyl-6-methyl-1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]-4-methylpiperazine-1-carboxamide;N-[5-(5-fluoro-6-methyl-1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]acetamide;N-[5-(5-fluoro-6-methyl-1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]-4-methylpiperazine-1-carboxamide;bis(N-[5-(5-fluoro-6-methyl-1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]piperidine-1-carboxamide);N-[5-[6-(trifluoromethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]acetamide
PubChem CID162183242
Molecular FormulaC109H117ClF7N41O7
Molecular Weight2281.85 g/mol
Exact Mass2279.96
IUPAC NameN-[5-(5-chloro-6-methyl-1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]acetamide;N-[5-(5-ethyl-6-methyl-1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]-4-methylpiperazine-1-carboxamide;N-[5-(5-fluoro-6-methyl-1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]acetamide;N-[5-(5-fluoro-6-methyl-1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]-4-methylpiperazine-1-carboxamide;bis(N-[5-(5-fluoro-6-methyl-1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]piperidine-1-carboxamide);N-[5-[6-(trifluoromethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]acetamide
SMILESCC(=O)Nc1cn[nH]c1-c1nc2cc(Cl)c(C)cc2[nH]1.CC(=O)Nc1cn[nH]c1-c1nc2cc(F)c(C)cc2[nH]1.CC(=O)Nc1cn[nH]c1-c1nc2ccc(C(F)(F)F)cc2[nH]1.CCc1cc2nc(-c3[nH]ncc3NC(=O)N3CCN(C)CC3)[nH]c2cc1C.Cc1cc2[nH]c(-c3[nH]ncc3NC(=O)N3CCCCC3)nc2cc1F.Cc1cc2[nH]c(-c3[nH]ncc3NC(=O)N3CCCCC3)nc2cc1F.Cc1cc2[nH]c(-c3[nH]ncc3NC(=O)N3CCN(C)CC3)nc2cc1F
InChIInChI=1S/C19H25N7O.C17H20FN7O.2C17H19FN6O.C13H12ClN5O.C13H10F3N5O.C13H12FN5O/c1-4-13-10-15-14(9-12(13)2)21-18(22-15)17-16(11-20-24-17)23-19(27)26-7-5-25(3)6-8-26;1-10-7-12-13(8-11(10)18)21-16(20-12)15-14(9-19-23-15)22-17(26)25-5-3-24(2)4-6-25;2*1-10-7-12-13(8-11(10)18)21-16(20-12)15-14(9-19-23-15)22-17(25)24-5-3-2-4-6-24;1-6-3-9-10(4-8(6)14)18-13(17-9)12-11(5-15-19-12)16-7(2)20;1-6(22)18-10-5-17-21-11(10)12-19-8-3-2-7(13(14,15)16)4-9(8)20-12;1-6-3-9-10(4-8(6)14)18-13(17-9)12-11(5-15-19-12)16-7(2)20/h9-11H,4-8H2,1-3H3,(H,20,24)(H,21,22)(H,23,27);7-9H,3-6H2,1-2H3,(H,19,23)(H,20,21)(H,22,26);2*7-9H,2-6H2,1H3,(H,19,23)(H,20,21)(H,22,25);3-5H,1-2H3,(H,15,19)(H,16,20)(H,17,18);2-5H,1H3,(H,17,21)(H,18,22)(H,19,20);3-5H,1-2H3,(H,15,19)(H,16,20)(H,17,18)
InChIKeyZPHYPECYSQOADF-UHFFFAOYSA-N
XLogP19.78
TPSA624.66 Ų
H-Bond Donors21
H-Bond Acceptors23
Rotatable Bonds15
Heavy Atoms165
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002281.85
LogP ≤ 519.78
H-Bond Donors ≤ 521
H-Bond Acceptors ≤ 1023

Analyze N-[5-(5-chloro-6-methyl-1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]acetamide;N-[5-(5-ethyl-6-methyl-1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]-4-methylpiperazine-1-carboxamide;N-[5-(5-fluoro-6-methyl-1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]acetamide;N-[5-(5-fluoro-6-methyl-1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]-4-methylpiperazine-1-carboxamide;bis(N-[5-(5-fluoro-6-methyl-1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]piperidine-1-carboxamide);N-[5-[6-(trifluoromethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]acetamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-[5-(5-chloro-6-methyl-1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]acetamide;N-[5-(5-ethyl-6-methyl-1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]-4-methylpiperazine-1-carboxamide;N-[5-(5-fluoro-6-methyl-1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]acetamide;N-[5-(5-fluoro-6-methyl-1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]-4-methylpiperazine-1-carboxamide;bis(N-[5-(5-fluoro-6-methyl-1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]piperidine-1-carboxamide);N-[5-[6-(trifluoromethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]acetamide?
The IUPAC name of N-[5-(5-chloro-6-methyl-1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]acetamide;N-[5-(5-ethyl-6-methyl-1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]-4-methylpiperazine-1-carboxamide;N-[5-(5-fluoro-6-methyl-1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]acetamide;N-[5-(5-fluoro-6-methyl-1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]-4-methylpiperazine-1-carboxamide;bis(N-[5-(5-fluoro-6-methyl-1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]piperidine-1-carboxamide);N-[5-[6-(trifluoromethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]acetamide (CID 162183242) is N-[5-(5-chloro-6-methyl-1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]acetamide;N-[5-(5-ethyl-6-methyl-1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]-4-methylpiperazine-1-carboxamide;N-[5-(5-fluoro-6-methyl-1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]acetamide;N-[5-(5-fluoro-6-methyl-1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]-4-methylpiperazine-1-carboxamide;bis(N-[5-(5-fluoro-6-methyl-1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]piperidine-1-carboxamide);N-[5-[6-(trifluoromethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]acetamide.
What is the SMILES notation for N-[5-(5-chloro-6-methyl-1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]acetamide;N-[5-(5-ethyl-6-methyl-1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]-4-methylpiperazine-1-carboxamide;N-[5-(5-fluoro-6-methyl-1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]acetamide;N-[5-(5-fluoro-6-methyl-1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]-4-methylpiperazine-1-carboxamide;bis(N-[5-(5-fluoro-6-methyl-1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]piperidine-1-carboxamide);N-[5-[6-(trifluoromethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]acetamide?
The canonical SMILES for N-[5-(5-chloro-6-methyl-1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]acetamide;N-[5-(5-ethyl-6-methyl-1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]-4-methylpiperazine-1-carboxamide;N-[5-(5-fluoro-6-methyl-1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]acetamide;N-[5-(5-fluoro-6-methyl-1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]-4-methylpiperazine-1-carboxamide;bis(N-[5-(5-fluoro-6-methyl-1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]piperidine-1-carboxamide);N-[5-[6-(trifluoromethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]acetamide is CC(=O)Nc1cn[nH]c1-c1nc2cc(Cl)c(C)cc2[nH]1.CC(=O)Nc1cn[nH]c1-c1nc2cc(F)c(C)cc2[nH]1.CC(=O)Nc1cn[nH]c1-c1nc2ccc(C(F)(F)F)cc2[nH]1.CCc1cc2nc(-c3[nH]ncc3NC(=O)N3CCN(C)CC3)[nH]c2cc1C.Cc1cc2[nH]c(-c3[nH]ncc3NC(=O)N3CCCCC3)nc2cc1F.Cc1cc2[nH]c(-c3[nH]ncc3NC(=O)N3CCCCC3)nc2cc1F.Cc1cc2[nH]c(-c3[nH]ncc3NC(=O)N3CCN(C)CC3)nc2cc1F.
What is the InChIKey of N-[5-(5-chloro-6-methyl-1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]acetamide;N-[5-(5-ethyl-6-methyl-1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]-4-methylpiperazine-1-carboxamide;N-[5-(5-fluoro-6-methyl-1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]acetamide;N-[5-(5-fluoro-6-methyl-1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]-4-methylpiperazine-1-carboxamide;bis(N-[5-(5-fluoro-6-methyl-1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]piperidine-1-carboxamide);N-[5-[6-(trifluoromethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]acetamide?
The InChIKey is ZPHYPECYSQOADF-UHFFFAOYSA-N. The full InChI is InChI=1S/C19H25N7O.C17H20FN7O.2C17H19FN6O.C13H12ClN5O.C13H10F3N5O.C13H12FN5O/c1-4-13-10-15-14(9-12(13)2)21-18(22-15)17-16(11-20-24-17)23-19(27)26-7-5-25(3)6-8-26;1-10-7-12-13(8-11(10)18)21-16(20-12)15-14(9-19-23-15)22-17(26)25-5-3-24(2)4-6-25;2*1-10-7-12-13(8-11(10)18)21-16(20-12)15-14(9-19-23-15)22-17(25)24-5-3-2-4-6-24;1-6-3-9-10(4-8(6)14)18-13(17-9)12-11(5-15-19-12)16-7(2)20;1-6(22)18-10-5-17-21-11(10)12-19-8-3-2-7(13(14,15)16)4-9(8)20-12;1-6-3-9-10(4-8(6)14)18-13(17-9)12-11(5-15-19-12)16-7(2)20/h9-11H,4-8H2,1-3H3,(H,20,24)(H,21,22)(H,23,27);7-9H,3-6H2,1-2H3,(H,19,23)(H,20,21)(H,22,26);2*7-9H,2-6H2,1H3,(H,19,23)(H,20,21)(H,22,25);3-5H,1-2H3,(H,15,19)(H,16,20)(H,17,18);2-5H,1H3,(H,17,21)(H,18,22)(H,19,20);3-5H,1-2H3,(H,15,19)(H,16,20)(H,17,18).
What are the key properties of N-[5-(5-chloro-6-methyl-1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]acetamide;N-[5-(5-ethyl-6-methyl-1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]-4-methylpiperazine-1-carboxamide;N-[5-(5-fluoro-6-methyl-1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]acetamide;N-[5-(5-fluoro-6-methyl-1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]-4-methylpiperazine-1-carboxamide;bis(N-[5-(5-fluoro-6-methyl-1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]piperidine-1-carboxamide);N-[5-[6-(trifluoromethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]acetamide?
N-[5-(5-chloro-6-methyl-1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]acetamide;N-[5-(5-ethyl-6-methyl-1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]-4-methylpiperazine-1-carboxamide;N-[5-(5-fluoro-6-methyl-1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]acetamide;N-[5-(5-fluoro-6-methyl-1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]-4-methylpiperazine-1-carboxamide;bis(N-[5-(5-fluoro-6-methyl-1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]piperidine-1-carboxamide);N-[5-[6-(trifluoromethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]acetamide has a molecular weight of 2281.85 g/mol, XLogP of 19.78, 15 rotatable bonds, 21 hydrogen bond donors, and 23 hydrogen bond acceptors.
Where does this data come from?
All data for N-[5-(5-chloro-6-methyl-1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]acetamide;N-[5-(5-ethyl-6-methyl-1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]-4-methylpiperazine-1-carboxamide;N-[5-(5-fluoro-6-methyl-1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]acetamide;N-[5-(5-fluoro-6-methyl-1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]-4-methylpiperazine-1-carboxamide;bis(N-[5-(5-fluoro-6-methyl-1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]piperidine-1-carboxamide);N-[5-[6-(trifluoromethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]acetamide is sourced from PubChem (CID 162183242), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).